Corline Biomedical AB (STO:CLBIO)
Sweden · Delayed Price · Currency is SEK 14.25
+0.05 (0.35%)
Sep 22, 2026, 1:48 PM CET
Corline Biomedical AB Market Cap
Corline Biomedical AB has a market cap or net worth of 372.4 million as of September 22, 2026. Its market cap has increased by 2.39% in one year.
Market Cap
372.40M
Enterprise Value
344.32M
Revenue
12.39M
Ranking
n/a
PE Ratio
n/a
Stock Price
14.25
ChartMarket Cap Chart
Since June 3, 2015, Corline Biomedical AB's market cap has increased from 97.97M to 372.40M, an increase of 280.13%. That is a compound annual growth rate of 12.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 372.40M | 5.66% |
| Dec 30, 2025 | 352.45M | 86.79% |
| Dec 30, 2024 | 188.69M | -41.07% |
| Dec 29, 2023 | 320.21M | 61.61% |
| Dec 30, 2022 | 198.15M | -36.85% |
| Dec 30, 2021 | 313.77M | 25.86% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oncopeptides AB | 816.66M |
| FluoGuide | 572.23M |
| Xspray Pharma AB | 442.87M |
| Mendus AB | 428.39M |
| Cantargia AB | 390.07M |
| Intervacc AB | 344.22M |
| Sprint Bioscience AB | 311.27M |
| IRLAB Therapeutics AB | 256.68M |